4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

por Strijbis, Eva MM, Nij Bijvank, Jenny A, Killestein, Joep
Publicado 2020

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis

por Balk, Lisanne J, Coric, Danko, Nij Bijvank, Jenny A, Killestein, Joep, Uitdehaag, Bernard MJ, Petzold, Axel
Publicado 2017

A novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage

por Nij Bijvank, Jenny A, Hof, Sam N, Prouskas, Stefanos E, Schoonheim, Menno M, Uitdehaag, Bernard M J, van Rijn, Laurentius J, Petzold, Axel
Publicado 2022

A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia

por Nij Bijvank, Jenny A., Sánchez Aliaga, Esther, Balk, Lisanne J., Coric, Danko, Davagnanam, Indran, Tan, H. Stevie, Uitdehaag, Bernard M. J., van Rijn, Laurentius J., Petzold, Axel
Publicado 2021

Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial

por Kanhai, Kawita M. S., Nij Bijvank, Jenny A., Wagenaar, Yorick L., Klaassen, Erica S., Lim, KyoungSoo, Bergheanu, Sandrin C., Petzold, Axel, Verma, Ajay, Hesterman, Jacob, Wattjes, Mike P., Uitdehaag, Bernard M. J., van Rijn, Laurentius J., Groeneveld, Geert Jan
Publicado 2019

Artificial intelligence extension of the OSCAR‐IB criteria

por Petzold, Axel, Albrecht, Philipp, Balcer, Laura, Bekkers, Erik, Brandt, Alexander U., Calabresi, Peter A., Deborah, Orla Galvin, Graves, Jennifer S., Green, Ari, Keane, Pearse A, Nij Bijvank, Jenny A., Sander, Josemir W., Paul, Friedemann, Saidha, Shiv, Villoslada, Pablo, Wagner, Siegfried K, Yeh, E. Ann
Publicado 2021